Skip to content
PubMed This is a summary of 8 peer-reviewed journal articles Updated
Pulmonology · Pulmonary Hypertension

Why Is a V/Q Scan Needed for Pulmonary Hypertension?

At a Glance

V/Q scanning is the preferred screening test for unexplained pulmonary hypertension because it is highly sensitive for chronic blood-clot blockages, which can reveal a potentially treatable form called chronic thromboembolic pulmonary hypertension (CTEPH).

If you have already been told you have high blood pressure in your lungs, it is completely normal to feel exhausted by the constant medical tests. You might wonder why your medical team is strongly recommending yet another imaging test—a V/Q scan (ventilation/perfusion scan)—when an echocardiogram or right heart catheterization has already shown that your pressures are high.

The short answer is that a V/Q scan is the preferred screening test to check if your pulmonary hypertension is being caused by old, chronic blood clots [1]. This specific condition is called Chronic Thromboembolic Pulmonary Hypertension (CTEPH).

Even though your doctors know your pulmonary pressures are high, they must determine the underlying cause. Idiopathic pulmonary arterial hypertension (IPAH) and CTEPH may share similar symptoms, but their treatment pathways are very different [2].

The Search for a Treatable Cause

When a fresh blood clot travels to the lungs (a pulmonary embolism), the body’s natural systems usually break it down over time, while blood thinners are used to prevent new clots from forming. However, in some people, these clots do not fully dissolve. Instead, they turn into permanent, scar-like blockages in the lung’s blood vessels, leading to high pressure and right heart strain [3]. You can develop CTEPH even if you do not remember ever having a blood clot in the past [1].

The most important reason to screen for CTEPH is that it has unique, highly effective treatments. For eligible patients, a specialized surgery called pulmonary endarterectomy (PTE) can remove the blockages and is potentially curative [3][2]. For those who are not candidates for surgery, there are other targeted options, such as balloon pulmonary angioplasty or specific medications, along with lifelong anticoagulation [2]. Because IPAH is treated primarily with medications that relax the blood vessels (vasodilators), it is crucial not to miss a CTEPH diagnosis [2].

Why a V/Q Scan Instead of a CT Scan?

You may have already had a standard chest CT scan and wonder why that is not enough. While CT scans are excellent for finding fresh blood clots, they can easily miss the old, flattened, scar-like lesions of CTEPH [1]. Even a specialized CT pulmonary angiogram (CTPA) can sometimes miss subtle chronic changes unless read by a CTEPH expert [4].

A V/Q scan takes a different approach. It uses a very low dose of radiation (inhaled and injected) to measure the actual flow of air (ventilation) and blood (perfusion) through your lungs. You should let your care team know if you are pregnant or breastfeeding, but the test is generally well-tolerated. V/Q scans are highly sensitive for detecting the specific “mismatched” blood flow patterns caused by CTEPH [5]. Because of this high sensitivity, international medical guidelines strongly recommend a V/Q scan as the primary screening tool for anyone with unexplained pulmonary hypertension [1][2].

What the Results Mean

  • If the scan is normal: CTEPH is considered very unlikely [1][6]. However, a normal V/Q scan does not automatically prove you have IPAH; it simply crosses CTEPH off the list. Your doctor will still need to rule out other causes and confirm your pressures with a right heart catheterization [7].
  • If the scan is abnormal: This does not immediately prove you have CTEPH or a fresh blood clot. Other lung conditions can also cause irregular scan results [8]. If your scan shows “mismatched defects” (areas that get air but no blood flow), you will likely be referred to a specialized pulmonary hypertension center. There, experts will use confirmatory imaging, like a CTPA or a pulmonary angiogram, to map out the blood vessels and discuss your treatment options [7][2].

While “scan fatigue” is a very real and valid feeling during the diagnostic process, the V/Q scan is a vital safety step to ensure a potentially treatable condition is not overlooked.

Common questions in this guide

Why is a V/Q scan recommended if I already have pulmonary hypertension?
A V/Q scan looks for old, organized blood-clot blockages in the lung blood vessels, which can cause chronic thromboembolic pulmonary hypertension (CTEPH). It is highly sensitive for the mismatched pattern in which air reaches an area but blood flow does not. Finding CTEPH matters because it can be treated differently from idiopathic pulmonary arterial hypertension, including potentially curative surgery for some patients.
Can a normal V/Q scan rule out chronic blood-clot pulmonary hypertension?
A normal V/Q scan makes CTEPH very unlikely. It does not by itself prove idiopathic pulmonary arterial hypertension or explain every case of high pressure in the lungs, so clinicians may still use other tests, including right heart catheterization to measure pressure directly.
Does an abnormal V/Q scan confirm CTEPH?
No. An abnormal scan, especially one showing mismatched perfusion defects, can occur with conditions other than CTEPH and does not by itself prove an old or new clot. Doctors often refer patients to a specialized pulmonary hypertension center for confirmatory CT pulmonary angiography or pulmonary angiography and treatment planning.
Why might my CT scan not be enough to find CTEPH?
A standard chest CT is good at finding fresh clots but may miss the flattened, scar-like blockages left by older clots. Even CT pulmonary angiography can miss subtle chronic changes unless an experienced CTEPH team reviews it, so V/Q scanning is preferred for initial screening.
What treatments are possible if the V/Q scan suggests CTEPH?
A specialized team assesses whether a surgery called pulmonary endarterectomy can remove the chronic blockages and potentially cure the condition. If surgery is not suitable, options can include balloon pulmonary angioplasty, targeted medication, and lifelong anticoagulation.

Get notified when new evidence is published on Idiopathic/heritable pulmonary arterial hypertension.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (8)
  1. 1

    Perfusion Scintigraphy in Diagnosis and Management of Thromboembolic Pulmonary Hypertension.

    Moradi F, Morris TA, Hoh CK

    Radiographics : a review publication of the Radiological Society of North America, Inc 2019; (39(1)):169-185 doi:10.1148/rg.2019180074.

    PMID: 30620694
  2. 2

    Chronic Thromboembolic Pulmonary Hypertension.

    Teerapuncharoen K, Bag R

    Lung 2022; (200(3)):283-299 doi:10.1007/s00408-022-00539-w.

    PMID: 35643802
  3. 3

    Chronic thromboembolic pulmonary hypertension: a distinct disease entity.

    Lang I

    European respiratory review : an official journal of the European Respiratory Society 2015; (24(136)):246-52 doi:10.1183/16000617.00001115.

    PMID: 26028636
  4. 4

    The diagnostic performance of CT pulmonary angiography in the detection of chronic thromboembolic pulmonary hypertension-systematic review and meta-analysis.

    Lambert L, Michalek P, Burgetova A

    European radiology 2022; (32(11)):7927-7935 doi:10.1007/s00330-022-08804-5.

    PMID: 35482124
  5. 5

    Lung Ventilation/Perfusion Scintigraphy for the Screening of Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Which Criteria to Use?

    Le Pennec R, Tromeur C, Orione C, et al.

    Frontiers in medicine 2022; (9()):851935 doi:10.3389/fmed.2022.851935.

    PMID: 35321469
  6. 6

    Dual-energy CT (DECT) lung perfusion in pulmonary hypertension: concordance rate with V/Q scintigraphy in diagnosing chronic thromboembolic pulmonary hypertension (CTEPH).

    Masy M, Giordano J, Petyt G, et al.

    European radiology 2018; (28(12)):5100-5110 doi:10.1007/s00330-018-5467-2.

    PMID: 29846802
  7. 7

    Evaluation and Management of Chronic Thromboembolic Pulmonary Hypertension.

    Yang J, Madani MM, Mahmud E, Kim NH

    Chest 2023; (164(2)):490-502 doi:10.1016/j.chest.2023.03.029.

    PMID: 36990148
  8. 8

    Mimickers of chronic thromboembolic pulmonary hypertension on imaging tests: a review.

    Narechania S, Renapurkar R, Heresi GA

    Pulmonary circulation 2020; (10(1)):2045894019882620 doi:10.1177/2045894019882620.

    PMID: 32257112

This page explains why a V/Q scan may be used when evaluating pulmonary hypertension for informational purposes only and does not constitute medical advice. Discuss your results and next steps with your pulmonary hypertension team.